Step 8: tool results

{
  "status": "doubtful",
  "claim_id": "ce83c0f0-e756-4e41-89d8-86d2f16dc9c3",
  "assessment": "Some AI systems have proposed experimental-science hypotheses that later held up in the laboratory. The clearest documented case is [[claim:474f2f6a-3f2c-4294-b232-86767bcbb595|the laboratory validation of hypotheses from Google's AI Co-Scientist]]: drug-repurposing candidates for acute myeloid leukemia confirmed in vitro, and epigenetic targets for liver fibrosis supported in human organoids. These cases show that the capability exists. The claim, however, says AI does this reliably, and that is what the evidence has not shown.\n\nThe main gap is the absence of base rates. The published successes were chosen by expert collaborators from large ranked candidate lists and tested by the developers' co-authors. No study has reported what share of AI-proposed hypotheses, drawn from an unselected pool, survive experimental testing, or how that share compares with hypotheses written by human experts. If AI systems reliably produced validated hypotheses, hit rates of that kind would be the natural thing for developers to publish, so their absence counts modestly against the claim.\n\nThe one controlled study of execution outcomes points the same way, though it does not measure validation directly. Si, Hashimoto and Yang (2025) found that [[claim:2e6a6348-a373-48b5-b7fa-f26a3c3342c5|LLM-generated research ideas lose their advantage over expert ideas when actually executed]]. That result is comparative and comes from computational NLP research, so it says nothing about absolute success rates in laboratory science. Its relevance is narrower: it shows that ideas judged highly novel at the proposal stage fare worse once tested, so favourable proposal-stage ratings cannot stand in for validation, and it gives no sign that AI ideas outperform expert ones after execution.\n\nThe verdict would change with validation rates for AI-generated hypotheses from unselected or pre-registered pools, tested against human-generated controls in experimental fields.",
  "confidence": 0.6,
  "claim_credence": 0.3,
  "marginal_yield": 0.45,
  "reasoning_trace": "This pass was prompted by a consistency flag arguing that the earlier assessment over-read the execution study as evidence against the claim. The flag is partly right, and the reasoning has been corrected.\n\nThe execution study (arXiv 2506.20803, abstract read this pass) reports that after 43 experts each spent over 100 hours executing randomly assigned ideas, the blind review scores of LLM ideas fell significantly more than those of expert ideas on novelty, excitement, effectiveness and overall (p < 0.05). This closed the ideation-stage gap, and on several metrics human ideas ended up ahead. The study is comparative, in NLP prompting research, and has no absolute validation endpoint. It is therefore weak and indirect evidence on this claim. What it undercuts is the inference from \"LLM ideas are rated more novel\" to \"LLM ideas are good once tested.\" It does not show low absolute survival rates. The edge stays as evidence against, with its reasoning restated as weak and indirect.\n\nFor the claim, the Co-Scientist subclaim is now assessed as verified (credence 0.93): some hypotheses were lab-confirmed. Its limits are expert selection from ranked lists, validation by co-authoring collaborators, and in vitro or organoid endpoints. One case, the cf-PICI mechanism, was a rediscovery of a result humans had already found, not a new prediction. It establishes existence, not reliability.\n\nThe verdict rests mainly on the missing base rates, together with the expectation that a reliable capability would by late 2026 show up in reported hit rates from unselected pools. It rests only secondarily on the execution study. Reports of autonomous \"AI scientist\" pipelines with frequent flawed experiments point the same way but were not re-read this pass. Doubtful (credence 0.3), not contradicted: the evidence is indirect, and \"reliably\" sets no explicit threshold."
}

{
  "answers": [
    {
      "note": "Agreed that the execution study is comparative and does not measure absolute validation. I restated the edge and the reasoning so that it bears only weakly and indirectly: it undercuts proposal-stage ratings as a proxy for success. The verdict now rests mainly on the missing base rates. Doubtful at 0.30 stands, and it is consistent with the verified Co-Scientist existence claim.",
      "message": "m1",
      "outcome": "changed"
    },
    {
      "note": "Reassessed. I separated relative advantage from absolute validation, weighed the verified Co-Scientist cases as showing existence but not reliability, and made the missing unselected-pool base rates the main ground. The status and credence are unchanged.",
      "message": "m2",
      "outcome": "changed"
    }
  ]
}

{
  "claim_id": "ce83c0f0-e756-4e41-89d8-86d2f16dc9c3",
  "reasoning": "Responding to the consistency flag and the mandate's plan. I read the execution-study abstract and confirmed that it is comparative. I rewrote the contradicts edge reasoning as weak and indirect. I reweighted the assessment to rest primarily on the absent base rates and on the Co-Scientist subclaim, now verified, which shows existence only. Status doubtful, credence 0.30 and confidence 0.6 are unchanged, so no dependents need notifying.",
  "action_taken": "reassessed"
}